Citation
Select
Felden Pharmazentrum frankfurt/ZAFES, Institute of Clinical Pharmacology, Johann Wolfgang Goethe-University, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany., Walter C, Harder S, Treede RD, Kayser H, Drover D, Geisslinger G, Lötsch J
Comparative clinical effects of hydromorphone and morphine: a meta-analysis
Br J Anaesth. 2011 Sep;107(3):319-28
Citation
Select
Schonberg MA, Davis RB, McCarthy EP, Marcantonio ER
External validation of an index to predict up to 9-year mortality of community-dwelling adults aged 65 and older
J Am Geriatr Soc. 2011 Aug;59(8):1444-51
Citation
Select
COPD Clinical Research Network, Albert RK, Connett J, Bailey WC, Casaburi R, Cooper Jr, Criner GJ, Curtis JL, Dransfield MT, Han MK, Lazarus SC, Make B, Marchetti N, Martinez FJ, Madinger NE, McEvoy C, Niewoehner DE, Porsasz J, Price CS, Reilly J, Scanlon PD, Sciurba FC, Scharf SM, Washko GR, Woodruff PG, Anthonisen NR
Azithromycin for prevention of exacerbations of COPD
N Engl J Med. 2011 Aug 25;365(8):689-98
Citation
Select
the ROCKET AF Investigators, Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
N Engl J Med. 2011 Sep 8;365(10):883-91. Epub 2011 Aug 10
Citation
Select
the APPRAISE-2 Investigators, Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel JH, Cools F, Atar D, Leiva-Pons JL, Keltai M, Ogawa H, Pais P, Parkhomenko A, Ruzyllo W, Diaz R, White H, Ruda M, Geraldes M, Lawrence J, Harrington RA, Wallentin L
Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
N Engl J Med. 2011 Aug 25;365(8):699-708. [Epub 2011 Jul 24]